Recent Updates
July 14, 2010
Avandia: GlaxoSmithKline agrees to settle before FDA vote
June 27, 2010
Underinsured Motorist (UIM) Claims
June 24, 2010
Zimmer Duron Cup Hip Replacement Cases
June 24, 2010
DePuy ASR Hip Replacements
April 20, 2010
Steve Leshner Is Named a Super Lawyer for 2010
Archives
July, 2010
June, 2010
October, 2009
September, 2009
June, 2009
February, 2009
January, 2009
December, 2008
September, 2008
August, 2008
Avandia: GlaxoSmithKline agrees to settle before FDA vote
Posted by: Stephen Leshner
July 14, 2010
Topic: PRODUCT LIABILITY
The move comes as the Food and Drug Administration votes today whether or not to withdraw Avandia from the market over its heart attack risks.
GlaxoSmithKline will settle about ten-thousand lawsuits for an average payout of $46,000 apiece.
Avandia's U.S. sales comprised only a tiny one-and-a-half percent of the British drugmaker's 2009 sales.
Its withdrawal from the market could spur more lawsuits, however.
The FDA could choose to keep Avandia on the market but beef up its black-box warning about the risk of heart attacks.
The other option would be to further restrict Avandia's use.
Glaxo moved quickly after two U.S. Senators ratcheted up the pressure yesterday by releasing documents underscoring safety concerns with the drugs.
The documents showed Glaxo had tried to brush off scientific concerns about the increased risk of heart attack in users.
The FDA is also under pressure of its own, coming from consumer groups eager to test the Obama administration's promises of a more activist watchdog role for the agency.
If you or someone close to you has been injured as a result of taking Avandia, please call Steve Leshner.
